Citigroup Maintains Buy on Claritev, Raises Price Target to $45

Benzinga Newsdesk www.benzinga.com Positive 74.7%

Neg 0% Neu 0% Pos 74.7%

Citigroup analyst Daniel Grosslight maintains Claritev (NYSE:CTEV) with a Buy and raises the price target from $40 to $45.